Medline (MDLN) Depreciation & Amortization (CF) (2025 - 2026)
Medline (MDLN) reported Depreciation & Amortization (CF) of $254.0 million for Q1 2026, up 2.83% year-over-year from $247.0 million in Q1 2025, and up 2.83% on a QoQ basis from $247.0 million in Q1 2025.
Medline (MDLN) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $254.0 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 2.83% year-over-year to $254.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $501.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.0 billion, up 3.48% from the prior year.
- Depreciation & Amortization (CF) rose to $254.0 million in Q1 2026 per MDLN's latest filing, from $247.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $254.0 million in Q1 2026 and bottomed at $247.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 146.28 Bn | 141.88 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.14 Bn | 40.13 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 29.16 Bn | 35.00 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 27.13 Bn | 25.47 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 22.71 Bn | 22.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.26 Bn | 13.26 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Align Technology | 12.22 Bn | 11.16 Bn | 736.59 Mn | 56.55 Mn |
| 8 | Cooper Companies | 11.79 Bn | 11.66 Bn | 695.20 Mn | 95.50 Mn |
| 9 | Baxter International | 9.47 Bn | 7.42 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Aptargroup | 7.19 Bn | 6.99 Bn | 351.91 Mn | 64.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 254.00 Mn |
| Mar 28, 2026 | 254.00 Mn |
| Mar 29, 2025 | 247.00 Mn |
| Mar 29, 2025 | 247.00 Mn |